Our Latest Blogs

Updated May 2026. This article has been revised to reflect current preclinical research on multi-peptide metabolic stacks and updated regulatory context. The Skinny and Fit peptide...

GHK-Cu, the tripeptide complex glycine-histidine-lysine bound to a copper (II) ion, has emerged as one of the most extensively studied bioactive peptides in dermatological and rege...

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is one of the most extensively studied tripeptide-copper complexes in biochemical research. First isolated and characterized by Loren...

What does the BPC-157 research actually show? A breakdown of 2026 preclinical tissue repair findings, dosing data, and where the science stands.

Thymosin Alpha 1 is one of the most clinically documented peptides in immunology. Not documented as in “a few rodent studies” documented. As in approved for clinical us...

Research overview of IGF-1 LR3: the IGFBP binding protein problem, extended half-life chemistry, IGF1R signaling pathways, muscle satellite cell research, and in vitro versus in vi...

Tesamorelin is a synthetic GHRH analogue consisting of the complete 44-amino acid sequence of endogenous GHRH (growth hormone-releasing hormone) with a trans-3-hexenoic acid group ...

The CJC-1295/Ipamorelin combination is among the most studied dual-mechanism GH axis research designs in the peptide pharmacology literature. CJC-1295 is a GHRH analogue that ampli...

TB-500 is the synthetic form of the active region of Thymosin Beta-4 (TB4), a naturally occurring peptide originally isolated from thymus tissue and found throughout the body in co...